Syndax Pharmaceuticals (1T3.F) Q2 2025 Earnings

5MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.11
-0.99
-0.86
-0.74

Details

Expected EPS
-1.10680658088
Actual EPS
-0.8660652
Surprise EPS
0.24
Surprise Percent
+21.75%

Description

Syndax Pharmaceuticals (1T3.F) has reported earnings of -0.8660652 per share for Q2 2025.

0 Comments

Share your thoughts